A group of researchers in a recent study suggest the Trump administration’s proposal to include prescription drug prices in television advertisements contains a significant loophole through which drugmakers can make the on-air prices meaningless via modifiers, CNN reports.
According to the report, pharmaceutical companies have been lobbying for modifiers in drug ads for some time.
Johns Hopkins University’s Ge Bai, co-author of the study, says drugmakers will use the loophole to negate the Trump administration’s efforts.
“This regulation has good intentions, but the design of it leaves a huge loophole, and without getting rid of it, this law will have no effect,” she said. “The loophole is that pharmaceutical companies understand that modifiers work. They will do things to blunt what the administration is trying to achieve.”
To read the full report on CNN, click here.
